Zentalis Pharmaceuticals (ZNTL) Shares Issued (2020 - 2026)

Zentalis Pharmaceuticals has reported Shares Issued for 7 years, with the latest figure at $331000.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 75.13% year-over-year to $331000.0; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (up 1807.59% YoY), and the FY2025 full-year result was $5.4 million, up 1444.41% from the prior year.
• Shares Issued for Q1 2026 stood at $331000.0, down from $5.1 million in the prior quarter.
• The five-year high for Shares Issued was $234.1 million in Q4 2023, with the low at -$206.2 million in Q4 2022.
• Average Shares Issued over 5 years is $15.8 million, with a median of $320000.0 recorded in 2023.
• Year-over-year, Shares Issued slumped 222.77% in 2022 and surged 213.52% in 2023.
• Tracing ZNTL's Shares Issued over 5 years: stood at -$206.2 million in 2022, then surged by 213.52% to $234.1 million in 2023, then slumped by 99.96% to $92000.0 in 2024, then jumped by 5428.26% to $5.1 million in 2025, then sank by 93.49% to $331000.0 in 2026.
• The last three Shares Issued figures came in at $331000.0 (Q1 2026), $5.1 million (Q4 2025), and $115000.0 (Q3 2025), per Business Quant data.

Peer Comparison